14 May 2015 06:55
Hikma Pharmaceuticals on Tuesday launched a caffeine citrate injection to treat apnea resulting from prematurity in infants of between 28 and 33 weeks of gestational age. The company noted that sales of caffeine citrate injections in the US last year were of $7.6m. Chairman and chief executive Said
Read more